Appointed: July 1, 2015
Committee membership: Remuneration Committee and Nomination & Governance Committee
Skills & experience: Olivier brings to the Board his extensive international business and leadership experience gained through roles held in pharmaceutical and healthcare companies across Europe, the Middle East and the U.S. He is to be appointed Senior Independent Director with effect from the conclusion of the 2018 Annual General Meeting. He currently holds the position of Chief Executive Officer at Smith & Nephew plc, having previously served as Chief Executive Officer and President of Pierre Fabre Group and as President of Abbott Pharmaceuticals; a division of U.S.-based Abbott Laboratories. Olivier also held diverse commercial leadership positions at GlaxoSmithKline and its predecessor companies in France. He holds an MBA from HEC Paris School of Management and a doctorate in Pharmacy from the University of Paris.
Key appointments: Smith & Nephew plc (Chief Executive Officer), Biotech Promise (Non-Executive Director) and Virbac SA (Non-Executive Director).